Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 15/20 | 0.71 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.59 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.59 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | PTPN2 | P17706 | 6/20 | 0.46 |
| ▸ | PTPN6 | P29350 | 2/20 | 0.46 |
| ▸ | TOP2A | P11388 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Taraxerol SCHEMBL21264264 | 0.83 | PTPN1 (1.00) | PTPN1AKR1B10AKR1B1USP2PTPN2 | |
| Taraxerol SCHEMBL569463 | 0.83 | PTPN1 (1.00) | PTPN1AKR1B10AKR1B1USP2PTPN2 | |
| Taraxerol SCHEMBL15491005 | 0.83 | PTPN1 (1.00) | PTPN1AKR1B10AKR1B1USP2PTPN2 | |
| Taraxerol SCHEMBL14047708 | 0.83 | PTPN1 (1.00) | PTPN1AKR1B10AKR1B1USP2PTPN2 | |
| Taraxerol SCHEMBL15491002 | 0.83 | PTPN1 (1.00) | PTPN1AKR1B10AKR1B1USP2PTPN2 | |
| Taraxerol SCHEMBL569464 | 0.83 | PTPN1 (1.00) | PTPN1AKR1B10AKR1B1USP2PTPN2 | |
| SCHEMBL29934987 | 0.80 | CES2 (0.47) | PTPN1AKR1B10AKR1B1PTPN2 | |
| Aleuritolic Acid SCHEMBL438408 | 0.79 | PTPN1 (0.70) | PTPN1AKR1B10USP2PTPN2PTPN6 | |
| Erythrodiol SCHEMBL21183484 | 0.74 | PTPN1 (1.00) | PTPN1AKR1B10AKR1B1ALOX5USP2 | |
| Erythrodiol SCHEMBL18625203 | 0.74 | PTPN1 (1.00) | PTPN1AKR1B10AKR1B1ALOX5USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021072473-A1 | ANTIMICROBIALS AS FEED PRESERVATIVES | IRP Health Pty Ltd (AU) | 2021-04-22 | — | — | WO | claimed |
| US-20090022821-A1 | COMPOSITIONS FROM WAX MYRTLE FOR THE TREATMENT OF CANCER, CARDIOVASCULAR AND INFLAMMATORY DISEASES | DEV INDERJIT KUMAR | 2009-01-22 | — | — | US | claimed |
| US-20220291237-A1 | Gene Expression Inflammatory Age and Its Uses | Edifice Health, Inc. (US) | 2022-09-15 | — | — | US | disclosed |
| WO-2021072473-A1 | ANTIMICROBIALS AS FEED PRESERVATIVES | IRP Health Pty Ltd (AU) | 2021-04-22 | — | — | WO | disclosed |
| US-10456345-B2 | Further preparations of silk proteins, seed oils, monosaccharide, natural botanicals and polysaccharide mixtures in compositions for hair care or hair repair, and skin care and topical treatments | Ross, Valerie M. (US) | 2019-10-29 | — | — | US | disclosed |
| CN-103599146-B | A kind of preparation method of diuretic compositions and purposes | HUAIHAI INSTITUTE OF TECHNOLOGY (CN) | 2016-04-27 | — | — | CN | disclosed |
| US-20150209261-A1 | Further Preparations of Silk Proteins, Seed Oils, Monosaccharide, Natural Botanicals and Polysaccharide Mixtures in Compositions for Hair Care or Hair Repair, and Skin Care and Topical Treatments | ROSS VALERIE M (US) | 2015-07-30 | — | — | US | disclosed |
| US-9023404-B2 | Further preparations of silk proteins, seed oils, monosaccharide, natural botanicals and polysaccharide mixtures in compositions for hair care or hair repair, and skin care and topical treatments | Ross, Valerie (US) | 2015-05-05 | — | — | US | disclosed |
| CN-103599146-A | Preparation method and use of diuretic composition | HUAIHAI INST TECHNOLOGY | 2014-02-26 | — | — | CN | disclosed |
| US-20110311655-A1 | Further preparations of silk proteins, seed oils, monosaccharide, natural botanicals and polysaccharide mixtures in compositions for hair care or hair repair, and skin care and topical treatments | Ross, Dr. Valerie (US) | 2011-12-22 | — | — | US | disclosed |
| US-20090022821-A1 | COMPOSITIONS FROM WAX MYRTLE FOR THE TREATMENT OF CANCER, CARDIOVASCULAR AND INFLAMMATORY DISEASES | DEV INDERJIT KUMAR | 2009-01-22 | — | — | US | disclosed |
| US-20080057161-A1 | Functionalized coffee | SUNRISE COFFEE CO. | 2008-03-06 | — | — | US | disclosed |
| US-20080057162-A1 | Functionalized coffee | SUNRISE COFFEE CO. | 2008-03-06 | — | — | US | disclosed |
| EP-1659876-A2 | METHODS OF PRODUCING A FUNCTIONALIZED COFFEE | Sunrise Coffee Co (US) | 2006-05-31 | — | — | EP | disclosed |
| WO-2005016018-A2 | METHODS OF PRODUCING A FUNCTIONALIZED COFFEE | SUNRISE COFFEE CO. (US) | 2005-02-24 | — | — | WO | disclosed |
| US-20050031761-A1 | Methods of producing a functionalized coffee | SUNRISE COFFEE CO. | 2005-02-10 | — | — | US | disclosed |